Pain News and Research

Latest Pain News and Research

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.

12 May 2011

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

As one of the first medical centers in the Northwest to perform robotic-assisted surgery, Swedish is home to the fastest growing, most comprehensive and experienced robotic-assisted surgical program in the region. Swedish established the multidisciplinary, robotic-assisted surgical program in 2005 and has since performed more than 3,400 robotic-assisted surgeries -- more than any other program in the region.

12 May 2011

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.

12 May 2011

Kool Smiles inaugurates new San Angelo dental office

Kool Smiles, a leading dental health provider for children and adults, now has opened its doors to additional families in Texas with a new office location in San Angelo. Kool Smiles of San Angelo officially opened on February 7 as the organization continues to expand access to quality dental care for families in underserved communities across the nation.

12 May 2011

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Cedars-Sinai researchers have reported two advances in the understanding of Irritable Bowel Syndrome, the most common gastrointestinal disorder in the United States, affecting an estimated 30 million people.

12 May 2011

FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain

Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.

12 May 2011

Naurex announces completion of $18 million Series A financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.

11 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis patients treated with Cimzia, the only approved PEGylated anti-TNF, together with methotrexate, achieved a rapid response associated with improved long-term outcomes one year after treatment began.

11 May 2011

Scientists to develop 'eTraining' system for doctors and healthcare providers

Many people use fitness studios to get back into shape after an injury. Fraunhofer researchers are now developing a system that will provide doctors with data on the exercises people do on the various machines. This should help them plan better training programs.

11 May 2011

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib for the treatment of metastatic melanoma have been submitted to the U.S. Food and Drug Administration and the European Medicines Agency.

11 May 2011

Spinal manipulation as effective as microdiskectomy for patients with sciatica

In a recent study, "Manipulation or Microdisketomy for Sciatica? A Prospective Randomized Clinical Study," researchers concluded that spinal manipulation was just as effective as microdiskectomy for patients struggling with sciatica secondary to lumbar disk herniation.

11 May 2011

New drug targets bile acid to provide relief from constipation

Constipation is definitely not a glamorous topic. In reality, it affects nearly 30 million Americans and costs more than $1 billion annually to evaluate and treat. While not often life threatening, the pain, bloating, discomfort, and straining associated with constipation lead sufferers to focus on one thing - relief.

11 May 2011

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced financial results for the first quarter of 2011.

11 May 2011

AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products, today announced that the Company's Zhibai Dihuang Pill and Ciwujia Tablet have been approved for sale as traditional Chinese medicine in Hong Kong by Chinese Medicine Council of Hong Kong.

10 May 2011

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.

10 May 2011

Wealth, population size, race and age associate with local availability of hospice programs

Wealth, population size, race and age associate with the supply of hospice care available in a county, according to a study published in the Journal of Pain and Symptom Management this month.

10 May 2011

Skin cancer prevention tips for anglers

If you love fishing and want to enjoy it well into your senior years then don't mess around with the sun. That's the advice for the 1 million Minnesotans who are expected to hit the water on Saturday for Minnesota's Fishing Opener from a leading Edina plastic and reconstructive surgeon who has treated hundreds of patients over the course of his 15-year career for skin cancer and melanoma.

10 May 2011

HFA develops free 'Alzheimer's Disease and Hospice Care' online webinar

The Hospice Foundation of America has developed "Alzheimer's Disease and Hospice Care," a free online webinar that examines how hospice care can support patients and families coping with end-stage Alzheimer's disease and other dementias.

10 May 2011

IOF launches Vertebral Fracture Initiative for health professionals

Vertebral fractures are a common cause of pain and disability - and they are also powerful predictors of future spine and hip fractures. Yet there is evidence that many health professionals simply fail to recognize vertebral fractures in their patients. Even if the fractures are reported, appropriate intervention is often not initiated.

10 May 2011

Pain News and Research

Latest Pain News and Research

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Kool Smiles inaugurates new San Angelo dental office

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain

Naurex announces completion of $18 million Series A financing

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Scientists to develop 'eTraining' system for doctors and healthcare providers

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Spinal manipulation as effective as microdiskectomy for patients with sciatica

New drug targets bile acid to provide relief from constipation

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Wealth, population size, race and age associate with local availability of hospice programs

Skin cancer prevention tips for anglers

HFA develops free 'Alzheimer's Disease and Hospice Care' online webinar

IOF launches Vertebral Fracture Initiative for health professionals

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in